InvestorsHub Logo

Student of the Game

05/09/24 11:48 AM

#44126 RE: newmanhead #44125

Animal studies are obviously only to prove safety and, as far as I know only humans develop AMD. Clearly if CUBT is moving forward and planning human trials then the animal trials must have shown the safety in animals.

Remember that Metformin has been prescribed as a first line treatment for type 2 diabetes since 1995. CUBT is using Metformin in a topical eye solution.